VIRAMUNE

This brand name is authorized in United States. It is also authorized in Australia, Austria, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug VIRAMUNE contains one active pharmaceutical ingredient (API):

1
UNII 99DK7FVK1H - NEVIRAPINE
 

Nevirapine is a NNRTI of HIV-1. Nevirapine is a non-competitive inhibitor of the HIV-1 reverse transcriptase, but it does not have a biologically significant inhibitory effect on the HIV-2 reverse transcriptase or on eukaryotic DNA polymerases α, β, γ, or δ.

 
Read more about Nevirapine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J05AG01 Nevirapine J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AG Non-nucleoside reverse transcriptase inhibitors
Discover more medicines within J05AG01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 10303G, 10319D
EE Ravimiamet 1037113, 1082618, 1215380, 1422638, 1540279, 1540280, 1540291, 1540303
ES Centro de información online de medicamentos de la AEMPS 97055002
FI Lääkealan turvallisuus- ja kehittämiskeskus 133551, 383445, 403633
FR Base de données publique des médicaments 62228427, 63791738, 65501436, 69410368
GB Medicines & Healthcare Products Regulatory Agency 44508
HK Department of Health Drug Office 44098, 61394
IT Agenzia del Farmaco 033999018, 033999020, 033999032, 033999044, 033999057, 033999069, 033999071, 033999083, 033999095
JP 医薬品医療機器総合機構 6250013F1023
LT Valstybinė vaistų kontrolės tarnyba 1012281, 1012282, 1031182, 1056597, 1063659, 1063660, 1063661, 1063662, 1063663
MX Comisión Federal para la Protección contra Riesgos Sanitarios 550M98
NL Z-Index G-Standaard 14260638
NL Z-Index G-Standaard, PRK 49786, 52213, 99007, 99015
NZ Medicines and Medical Devices Safety Authority 8602
PL Rejestru Produktów Leczniczych 100100276, 100253206, 100253212, 100253229, 100279393
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W13091001, W57321001, W57323001, W57323002, W57323003
SG Health Sciences Authority 10516P, 14299P
TR İlaç ve Tıbbi Cihaz Kurumu 8699693010056
US FDA, National Drug Code 0597-0046, 0597-0047, 0597-0123
ZA Health Products Regulatory Authority 31/20.2.8/0640, 33/20.2.8/0504

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.